Global Influenza Treatment Market Size study & Forecast, by Treatment by Route of Administration, by Distribution Channel and Regional Analysis, 2023-2030

Description

List of Tables

Global Influenza Treatment Market is valued approximately USD 5.84 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.18% over the forecast period 2023-2030. Influenza treatment refers to the therapeutic interventions employed to alleviate the symptoms and complications associated with influenza, a highly contagious respiratory viral infection commonly known as the flu. The primary goals of influenza treatment are to reduce the severity and duration of symptoms, prevent complications, and limit the spread of the virus. The Influenza Treatment market is expanding because of factors such as increased prevalence of contagious respiratory illness, emerging prevalence of seasonal flu and rising drug approval activities.

As per the CDC, the impact of influenza in the United States is substantial, with an estimated 27 to 54 million cases, 300,000 to 650,000 hospitalizations, and 19,000 to 58,000 deaths annually between 2022 and 2023. Preliminary data also reveals around 9 million symptomatic cases, 4 million medical visits, 100,000 hospitalizations, and 5,000 deaths from 2021 to 2022. These figures underscore the significant public health challenge posed by influenza, emphasizing the need for effective preventive measures and treatments to mitigate its impact on individuals and healthcare systems. Thus rising prevalence of seasonal flu is driving the market growth. In addition, rising investment in research and development activities and increased public awareness about the severity of influenza is creating new opportunities for the market growth. However, the high cost of Influenza Treatment stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Influenza Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, rising disease prevalence, rising drug development activities in the region. Asia Pacific is expected to grow at a fastest rate during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for durg development, rising healthcare expenditure, and active participation of government and in the market space.

Major market player included in this report are:

NATCO Pharma Limited
Novartis AG
F. Hoffmann-La Roche Ltd
BioCryst Pharmaceuticals, Inc.
Sanofi
GSK plc.
Viatris Inc. (MYLAN)
Teva Pharmaceutical Industries Ltd.
Daiichi Sankyo Company, Limited.
AstraZeneca

Recent Developments in the Market:

In July 2023, Shionogi & Co., Ltd. has disclosed the submission of a supplemental New Drug Application (sNDA) for Xofluza. This application pertains to the pediatric population, specifically for children aged 5 to 12 years, and seeks approval for the use of Xofluza in both post-exposure prophylaxis and the treatment of influenza virus infections.
In April 2023, Nanjing Zenshine Pharmaceuticals revealed positive outcomes from the phase II trials of ZX-7101A, specifically designed to address acute uncomplicated influenza in adults

Global Influenza Treatment Market Report Scope:

Historical Data: 2020 - 2021
Base Year for Estimation: 2022
Forecast period: 2023-2030
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Treatment, Rout of Administration, Distribution Channel, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Treatment:

Peramivir
Zanamivir
Baloxavir Marboxil
Oseltamivir Phosphate
Others

By Route of Administration:

Oral
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Influenza Treatment Market, by region, 2020-2030 (USD Billion)
- 1.2.2. Influenza Treatment Market, by Treatment, 2020-2030 (USD Billion)
- 1.2.3. Influenza Treatment Market, by Route of Administration, 2020-2030 (USD Billion)
- 1.2.4. Influenza Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Influenza Treatment Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Influenza Treatment Market Dynamics

3.1. Influenza Treatment Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increased prevalence of contagious respiratory illness
  - 3.1.1.2. Emerging prevalence of seasonal flu
  - 3.1.1.3. Rising drug approval activities
- 3.1.2. Market Challenges
  - 3.1.2.1. High Cost of Influenza Treatment
  - 3.1.2.2. Stringent regulatory processes and delays in drug approvals
- 3.1.3. Market Opportunities
  - 3.1.3.1. Rising investment in research and development activities
  - 3.1.3.2. Increased public awareness about the severity of influenza

Chapter 4. Global Influenza Treatment Market: Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economic
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Influenza Treatment Market, by Treatment

5.1. Market Snapshot
5.2. Global Influenza Treatment Market by Treatment, Performance - Potential Analysis
5.3. Global Influenza Treatment Market Estimates & Forecasts by Treatment 2020-2030 (USD Billion)
5.4. Influenza Treatment Market, Sub Segment Analysis
- 5.4.1. Peramivir
- 5.4.2. Zanamivir
- 5.4.3. Baloxavir Marboxil
- 5.4.4. Oseltamivir Phosphate
- 5.4.5. Others

Chapter 6. Global Influenza Treatment Market, by Route of Administration

6.1. Market Snapshot
6.2. Global Influenza Treatment Market by Route of Administration, Performance - Potential Analysis
6.3. Global Influenza Treatment Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Influenza Treatment Market, Sub Segment Analysis
- 6.4.1. Oral
- 6.4.2. Others

Chapter 7. Global Influenza Treatment Market, by Distribution Channel

7.1. Market Snapshot
7.2. Global Influenza Treatment Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Influenza Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Influenza Treatment Market, Sub Segment Analysis
- 7.4.1. Hospital Pharmacies
- 7.4.2. Retail Pharmacies
- 7.4.3. Online Pharmacies

Chapter 8. Global Influenza Treatment Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Influenza Treatment Market, Regional Market Snapshot
8.4. North America Influenza Treatment Market
- 8.4.1. U.S. Influenza Treatment Market
  - 8.4.1.1. Treatment breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Influenza Treatment Market
8.5. Europe Influenza Treatment Market Snapshot
- 8.5.1. U.K. Influenza Treatment Market
- 8.5.2. Germany Influenza Treatment Market
- 8.5.3. France Influenza Treatment Market
- 8.5.4. Spain Influenza Treatment Market
- 8.5.5. Italy Influenza Treatment Market
- 8.5.6. Rest of Europe Influenza Treatment Market
8.6. Asia-Pacific Influenza Treatment Market Snapshot
- 8.6.1. China Influenza Treatment Market
- 8.6.2. India Influenza Treatment Market
- 8.6.3. Japan Influenza Treatment Market
- 8.6.4. Australia Influenza Treatment Market
- 8.6.5. South Korea Influenza Treatment Market
- 8.6.6. Rest of Asia Pacific Influenza Treatment Market
8.7. Latin America Influenza Treatment Market Snapshot
- 8.7.1. Brazil Influenza Treatment Market
- 8.7.2. Mexico Influenza Treatment Market
8.8. Middle East & Africa Influenza Treatment Market
- 8.8.1. Saudi Arabia Influenza Treatment Market
- 8.8.2. South Africa Influenza Treatment Market
- 8.8.3. Rest of Middle East & Africa Influenza Treatment Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. NATCO Pharma Limited
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Developments
- 9.3.2. Novartis AG
- 9.3.3. F. Hoffmann-La Roche Ltd
- 9.3.4. BioCryst Pharmaceuticals, Inc.
- 9.3.5. Sanofi S.A
- 9.3.6. GSK plc.
- 9.3.7. Viatris Inc. (MYLAN)
- 9.3.8. Teva Pharmaceutical Industries Ltd.
- 9.3.9. Daiichi Sankyo Company, Limited.
- 9.3.10. AstraZeneca

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Influenza Treatment Market, report scope
TABLE 2. Global Influenza Treatment Market estimates & forecasts by region 2020-2030 (USD Billion)
TABLE 3. Global Influenza Treatment Market estimates & forecasts by Treatment 2020-2030 (USD Billion)
TABLE 4. Global Influenza Treatment Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
TABLE 5. Global Influenza Treatment Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 6. Global Influenza Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Influenza Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Influenza Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Influenza Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Influenza Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Influenza Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Influenza Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Influenza Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Influenza Treatment Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Influenza Treatment Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Influenza Treatment Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Influenza Treatment Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Influenza Treatment Market
TABLE 71. List of primary sources, used in the study of global Influenza Treatment Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable.

LIST OF FIGURES

FIG 1. Global Influenza Treatment Market, research methodology
FIG 2. Global Influenza Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Influenza Treatment Market, key trends 2022
FIG 5. Global Influenza Treatment Market, growth prospects 2023-2030
FIG 6. Global Influenza Treatment Market, porters 5 force model
FIG 7. Global Influenza Treatment Market, pest analysis
FIG 8. Global Influenza Treatment Market, value chain analysis
FIG 9. Global Influenza Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Influenza Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Influenza Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Influenza Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Influenza Treatment Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Influenza Treatment Market, regional snapshot 2020 & 2030
FIG 15. North America Influenza Treatment Market 2020 & 2030 (USD Billion)
FIG 16. Europe Influenza Treatment Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Influenza Treatment Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Influenza Treatment Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Influenza Treatment Market 2020 & 2030 (USD Billion)